| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002773 | 康弘药业 | 31.45 | -3.47% | 11.24万 | 3.56亿 | | 688336 | 三生国健 | 57.27 | -2.54% | 3.35万 | 1.92亿 | | 688331 | 荣昌生物 | 100.28 | -1.95% | 6.56万 | 6.57亿 | | 688293 | 奥浦迈 | 56.09 | -1.60% | 1.11万 | 6233.60万 | | 603087 | 目李药业 | 71.68 | -1.58% | 8.23万 | 5.90 亿 | | 688278 | 特宝生物 | 74.98 | -1.19% | 2.01万 | 1.51亿 | | 688520 | 神州组胞 | 45.88 | -0.97% | 3.87万 | 1.77亿 | | 688488 | 艾迪药业 | 18.54 | -0.54% | 10.74万 | 1.98 Z | | 603590 | 康辰约业 | ...

今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 禽流感 | 6.89 | 军工信息化 | -4.70 | | 金属铅 | 6.22 | 太赫兹 | -4.42 | | 金属锌 | 5.85 | 同花顺新质50 | -4.24 | | 黄金概念 | 5.02 | 军民融合 | -3.87 | | 动物疫苗 | 4.89 | 卫星导航 | -3.84 | | 芬太尼 | 4.18 | 商业航天 | -3.56 | | 金属铜 | 3.81 | 国产航母 | -3.52 | | 猴痘概念 | 3.13 | 减速器 | -3.51 | | 生物疫苗 | 2.98 | 大飞机 | -3.39 | | 金属钴 | 2.70 | 成飞概念 | -3.35 | 截至1月26日收盘，生物疫苗概念上涨2.98%，位居概念板块涨幅第9，板块内，45股上涨，华兰疫苗、 金迪克等20%涨停，智飞生物、东方生物、康希诺等涨幅居前，分别上涨14.87%、12.36%、11.67%。 跌幅居前的有*ST万方、海欣股份、蓝晓科技等，分别下跌5 ...

截至1月26日收盘，禽流感概念上涨6.89%，位居概念板块涨幅第1，板块内，25股上涨，之江生物、华 兰疫苗等20%涨停，达安基因涨停，永顺生物、东方生物、莱茵生物等涨幅居前，分别上涨27.18%、 12.36%、9.05%。 今日涨跌幅居前的概念板块 （文章来源：证券时报网） 禽流感概念资金流入榜 物 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 禽流感 | 6.89 | 军工信息化 | -4.70 | | 金属铅 | 6.22 | 太赫兹 | -4.42 | | 金属锌 | 5.85 | 同花顺新质50 | -4.24 | | 黄金概念 | 5.02 | 军民融合 | -3.87 | | 动物疫苗 | 4.89 | 卫星导航 | -3.84 | | 芬太尼 | 4.18 | 商业航天 | -3.56 | | 金属铜 | 3.81 | 国产航母 | -3.52 | | 猴痘概念 | 3.13 | 减速器 | -3.51 | | 生物疫苗 | 2.98 | 大飞机 | -3.39 | | 金属钴 | 2.70 | 成飞概念 | -3 ...

Core Viewpoint - The A-share market shows a slight decline with the Shanghai Composite Index closing at 4132.61 points, just above the six-month moving average, indicating a mixed market sentiment [1]. Group 1: Market Performance - The total trading volume of A-shares reached 32,806.44 billion yuan today [1]. - The Shanghai Composite Index experienced a change of -0.09% [1]. Group 2: Stocks Above Six-Month Moving Average - A total of 112 A-shares have surpassed the six-month moving average, with notable stocks including Yongshun Biological, Maike Biological, and Hualan Biological, which have divergence rates of 22.01%, 19.44%, and 19.05% respectively [1]. - Stocks with smaller divergence rates that have just crossed the six-month moving average include Nikko Chemical, Luban Chemical, and Zhangjiagang Bank [1]. Group 3: Top Stocks by Divergence Rate - The top three stocks with the highest divergence rates are: - Yongshun Biological: 22.01% divergence, with a daily increase of 27.18% and a turnover rate of 38.08% [1]. - Maike Biological: 19.44% divergence, with a daily increase of 20.03% and a turnover rate of 17.51% [1]. - Hualan Biological: 19.05% divergence, with a daily increase of 20.00% and a turnover rate of 4.52% [1].

Market Overview - The Shanghai Composite Index experienced a sideways movement, while the Shenzhen Component Index and ChiNext Index fell nearly 1%. The trading volume reached 3.28 trillion yuan, with nearly 3,800 stocks declining across the Shanghai and Shenzhen markets [1] - Precious metals stocks surged, with companies like Zhongjin Gold and Western Gold hitting the daily limit. The pharmaceutical sector also saw strong performance, with stocks such as Capstone Bio and Maike Bio reaching the daily limit [1] Key Highlights Precious Metals - Gold and silver stocks saw significant gains, with multiple stocks like Silver Nonferrous and Sichuan Gold hitting the daily limit. On January 26, spot gold surged, breaking the $5,000 mark in the morning and later surpassing $5,100 per ounce, setting a new historical high [4] - Companies such as Zhongjin Gold and Western Gold reported increases of 10% and 9.99% respectively, with market capitalizations of 159.96 billion yuan and 334.91 billion yuan [6][10] Pharmaceuticals - The pharmaceutical sector experienced a notable rise, with stocks like Teva Pharmaceutical, Hualan Biological Engineering, and Luyin Pharmaceutical reaching the daily limit. The sector's performance was influenced by the recent outbreak of the Nipah virus in India, prompting increased vigilance in neighboring countries [8][9] - Teva Pharmaceutical's stock rose by 10.01%, while Hualan Biological Engineering surged by 20% [10] Cloud Computing - The cloud computing sector saw an uptick, with stocks like Hasen Co., Qunxing Toys, and Wangsu Technology hitting the daily limit. Amazon Web Services recently raised its EC2 machine learning capacity block prices by approximately 15%, indicating a significant shift in cloud computing pricing logic amid AI resource shortages [12][14] - Analysts predict that this price increase may trigger a chain reaction among cloud service providers, with domestic and international companies likely to follow suit [12][14] Other Sectors - The oil and gas sector saw a midday rally, with Zhongman Petroleum hitting the daily limit and China National Offshore Oil Corporation rising over 6% to reach a new high. However, the commercial aerospace concept experienced adjustments, with stocks like China Satellite and China Satcom hitting the daily limit [1] - The robotics and photovoltaic sectors showed mixed performance, while aerospace and semiconductor sectors faced the largest declines [14]

Group 1 - The Nipah virus outbreak in West Bengal, India, has led to 5 confirmed cases, including healthcare workers, with nearly 100 individuals under home quarantine [1][2] - The virus has a high fatality rate of over 40%, with some reports indicating rates as high as 75%, and there is currently no effective vaccine or treatment available [2][3] - The outbreak has prompted heightened public health alerts globally, with neighboring countries like Thailand and Nepal increasing their screening and quarantine measures for travelers from India [3] Group 2 - The A-share market saw a surge in stocks related to influenza, virus testing, and vaccines, with several companies hitting their daily price limits [1][4] - Companies like Zhijiang Biology and Hualan Vaccine confirmed they have relevant products but currently lack orders from India, while others like Antu Biology and Shuoshi Biology are actively promoting their technical capabilities in response to the outbreak [4][5] - Some vaccine companies, such as Jindike, have stated they do not have any products related to the Nipah virus, indicating a divergence in market reactions among different sectors [5][6]

Group 1 - The Nipah virus outbreak has been reported in West Bengal, India, with 5 confirmed cases, including healthcare workers, and one patient in critical condition [2] - The local government is taking measures to contain the virus spread, including home isolation for nearly 100 individuals and testing bats in local zoos [2] - Thailand's Civil Aviation Authority announced comprehensive screening for flights from West Bengal starting January 26 to prevent the virus from entering Thailand [3] Group 2 - In the A-share market, stocks related to vaccines, influenza, and biotechnology surged, with companies like Maike Biological, Cap Bio, and others hitting a 20% limit up [4] - The Wind popular concept index shows significant increases in vaccine-related stocks, with a rise of 6.59% [5] - Investors are inquiring about listed companies with products related to the Nipah virus on platforms like Shenzhen Stock Exchange Interactive and Shanghai Stock Exchange Interactive [5] Group 3 - The World Health Organization describes the Nipah virus as a zoonotic virus that can be transmitted from infected animals to humans, with a mortality rate typically over 40% [8] - Symptoms of human infection include acute respiratory infections and potentially fatal encephalitis, with an incubation period ranging from 4 to 14 days, and up to 45 days in some cases [8]

Market Overview - On January 26, the A-share market experienced fluctuations, with the Shenzhen Composite Index and the ChiNext Index opening high but closing lower, both dropping over 1% during the day. The Shanghai Composite Index fell by 0.09%, the Shenzhen Composite Index by 0.85%, and the ChiNext Index by 0.91%. The total market turnover reached 3.28 trillion yuan, an increase of 162.5 billion yuan compared to the previous trading day, with over 3,700 stocks declining [1]. Precious Metals Sector - The precious metals sector led the market gains, with Sichuan Gold (001337) achieving four consecutive trading limits in eight days. Other stocks such as Xiaocheng Technology (300139), Hunan Gold (002155), and Shengda Resources (000603) also hit the daily limit, while Zijin Mining (601899) reached a historical high [1]. - On January 26, spot gold prices surpassed $5,100 per ounce, peaking at $5,110.26 per ounce. Silver prices also surged, with spot silver reaching a high of $109.453 per ounce, marking an increase of over 51% in just 17 trading days [3]. Investment Demand and Market Trends - The rising gold prices have significantly boosted market demand for gold investment and reserves, leading to a surge in bank safe deposit box rentals. For instance, at the Shenzhen branch of China Merchants Bank, all 8,000 safe deposit boxes are fully rented, with 500 to 600 customers waiting to rent a box. Given the annual turnover of only 20 to 30 boxes, new customers may have to wait 5 to 6 years [3]. - The A-share flu vaccine sector also showed strength, with stocks like Da'an Gene (002030), Hualan Biological (301207), and Zhijiang Biology hitting the daily limit, while Yongshun Biological surged over 27% [3]. Other Sector Movements - The oil and gas sector saw continued strength, with China National Offshore Oil Corporation (600938) reaching a historical high, and other companies like Zhongjie Oil and China Petroleum rising over 5% [6]. - The Tencent Cloud concept experienced localized movements, with stocks like Qunxing Toys (002575) hitting the daily limit and others like Ruijie Networks (301165) rising over 10% following Tencent's announcement of a new AI assistant app [7].

Market Overview - On January 26, A-shares saw a collective decline with the Shanghai Composite Index down 0.09% at 4132 points, the Shenzhen Component down 0.85%, and the ChiNext Index down 0.91% [1][2] - The total market turnover reached 3.28 trillion yuan, an increase of 162.5 billion yuan compared to the previous trading day, with over 3700 stocks declining [1] Sector Performance - The commercial aerospace and satellite internet sectors experienced significant pullbacks, with stocks like China Satellite and Aerospace Development hitting the daily limit down [2][4] - The military industry sector also fell, with stocks such as Chaojie Co. dropping over 10% [2] - Conversely, international gold and silver prices surged to new highs, leading to a rally in precious metals and non-ferrous metals sectors, with stocks like Xiaocheng Technology and Western Gold hitting the daily limit up [2][10] - The outbreak of the Nipah virus in India caused a collective rise in the biopharmaceutical and vaccine sectors [2][14] Notable Stock Movements - In the military equipment sector, Aerospace Hanyu fell over 11%, while China Satellite and Aerospace Technology hit the daily limit down [4] - In the semiconductor equipment sector, stocks like Su Dawei and Wo Ge Optoelectronics saw significant declines, with some stocks dropping over 11% [5][8] - The humanoid robot sector also faced declines, with stocks like Haoshi Machinery and Lixing Co. dropping over 13% [6][9] - The biopharmaceutical sector saw notable gains, with stocks like Hualan Vaccine and Jindike hitting the daily limit up due to the Nipah virus outbreak [14] Investment Insights - The coal sector showed strength, with China Shenhua rising over 4% and other coal stocks following suit [18] - The insurance sector also performed well, with stocks like New China Life and China Pacific Insurance seeing gains [15][16] - The market outlook suggests a focus on sectors with performance verification, particularly in price increase chains, high-end manufacturing, and AI-related industries [19]

报道称，当地政府正采取措施遏制病毒传播，目前已有近百人被要求居家隔离。由于该病毒通常由蝙蝠 传染给人类，西孟加拉邦已要求该邦多个动物园对圈养的蝙蝠进行采样检测。 世卫组织公布的信息显示，自1998年以来，孟加拉国、印度、马来西亚、菲律宾和新加坡均报告过尼帕 病毒疫情。印度自2001年以来多次出现尼帕病毒疫情。2025年5月17日至7月12日期间，印度喀拉拉邦报 告了4例尼帕病毒感染病例，其中包括2例死亡病例。 生物疫苗概念26日盘中走势强劲，截至发稿，华兰疫苗、金迪克20%涨停，智飞生物涨超15%，沃森生 物、康希诺等涨超10%。 消息面上，据印度媒体报道，印度东部的西孟加拉邦近期出现尼帕病毒疫情，确诊病例已升至5例。感 染者正在该邦首府加尔各答及周边医院接受治疗，其中一名患者病情危重。 （文章来源：证券时报网） ...